Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine Consumption and Rate Control in Permanent Atrial Fibrillation: The CAFIB Trial

NCT07738523 is registered in ClinicalTrials.gov with Hospital Universitario Getafe as lead sponsor.

NCT NCT07738523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07738523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine Consumption and Rate Control in Permanent Atrial Fibrillation: The CAFIB Trial
Lead sponsor
Hospital Universitario Getafe
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 27, 2026
Completion date
March 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), caffeine abuse, coffee consumption, permanent atrial fibrillation